EVEROLD LONG TERM FOLLOW-UP

Recruiting Observational Study
Transplant; Complication, Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
260 (estimated)
Sponsor
University Hospital, Brest · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Long Term Follow up of EVEROLD study

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Informed patients participating to the EVEROLD study * Patient having completed the EVEROLD M12 follow-up visit * Patient agreeing to participate in the observational study Exclusion Criteria: * Opposition to the use his medical data * Patient under legal protection
Contacts

Yannick Le Meur

+330298347014

yannick.lemeur@chu-brest.fr

CONTACT

Christelle RATAJCZAK

+330298347061

christelle.ratajczak@chu-brest.fr

CONTACT